DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.

Savitz, Jonathan

DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. [electronic resource] - The international journal of neuropsychopharmacology Oct 2013 - 2095-101 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

1469-5111

10.1017/S146114571300045X doi


Adult
Brain--diagnostic imaging
Case-Control Studies
Depressive Disorder, Major--diagnostic imaging
Dopamine Antagonists--metabolism
Female
Gambling
Genotype
Humans
Male
Middle Aged
Phenotype
Polymorphism, Single Nucleotide
Positron-Emission Tomography
Raclopride--metabolism
Receptors, Dopamine D2--genetics
Receptors, Dopamine D3--metabolism
Reward